LU87102A1 - Combinaison iyophilisee ou precipitee de zwitterbn de cephalosporine et de sel - Google Patents

Combinaison iyophilisee ou precipitee de zwitterbn de cephalosporine et de sel Download PDF

Info

Publication number
LU87102A1
LU87102A1 LU87102A LU87102A LU87102A1 LU 87102 A1 LU87102 A1 LU 87102A1 LU 87102 A LU87102 A LU 87102A LU 87102 A LU87102 A LU 87102A LU 87102 A1 LU87102 A1 LU 87102A1
Authority
LU
Luxembourg
Prior art keywords
zwitterion
composition according
chloride
antibiotic composition
salt
Prior art date
Application number
LU87102A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU87102A1 publication Critical patent/LU87102A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
LU87102A 1987-01-09 1988-01-08 Combinaison iyophilisee ou precipitee de zwitterbn de cephalosporine et de sel LU87102A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US194587 1987-01-09
US07/001,945 US4808617A (en) 1985-12-18 1987-01-09 Lyophilized or precipitated cephalosporin zwitterion and salt combination

Publications (1)

Publication Number Publication Date
LU87102A1 true LU87102A1 (fr) 1988-08-23

Family

ID=21698538

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87102A LU87102A1 (fr) 1987-01-09 1988-01-08 Combinaison iyophilisee ou precipitee de zwitterbn de cephalosporine et de sel

Country Status (33)

Country Link
US (1) US4808617A (ja)
JP (1) JP2568226B2 (ja)
KR (1) KR950010154B1 (ja)
AR (1) AR243501A1 (ja)
AT (1) AT388672B (ja)
AU (1) AU606361B2 (ja)
BE (1) BE1002114A3 (ja)
CA (1) CA1307464C (ja)
CH (1) CH676202A5 (ja)
CS (1) CS265249B2 (ja)
CY (1) CY1679A (ja)
DD (1) DD264614A5 (ja)
DE (1) DE3740588C2 (ja)
DK (1) DK166404B1 (ja)
ES (1) ES2008951A6 (ja)
FI (1) FI89006C (ja)
FR (1) FR2609396B1 (ja)
GB (1) GB2199746B (ja)
GR (1) GR871860B (ja)
HK (1) HK5593A (ja)
HU (1) HU199686B (ja)
IE (1) IE61238B1 (ja)
IL (1) IL84346A (ja)
IT (1) IT1215666B (ja)
LU (1) LU87102A1 (ja)
NL (1) NL193266C (ja)
OA (1) OA08796A (ja)
PT (1) PT86157B (ja)
SE (1) SE467910B (ja)
SG (1) SG114792G (ja)
SU (1) SU1575942A3 (ja)
YU (1) YU46689B (ja)
ZA (1) ZA88114B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
WO2005094800A2 (en) * 2004-03-31 2005-10-13 Lupin Ltd. A co-precipitated cefepime composition and process for preparation thereof
WO2006109324A2 (en) * 2005-04-13 2006-10-19 Lupin Limited Processes for preparation of amorphous cefepime acid addition salts
JP5491119B2 (ja) * 2009-10-02 2014-05-14 日東電工株式会社 薬物含有微粒子を含む医薬組成物およびその製造方法
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
JP6218204B2 (ja) 2014-09-04 2017-10-25 塩野義製薬株式会社 カテコール基を有するセファロスポリン類を含有する製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953439A (en) * 1973-08-01 1976-04-27 Smithkline Corporation Substituted phenylglycylcephalosporins
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4604386A (en) * 1984-07-09 1986-08-05 Eli Lilly And Company 3-(alkynylalkyloxy) cephalosporins
JPS61130223A (ja) * 1984-11-28 1986-06-18 Shionogi & Co Ltd 抗菌性凍結乾燥製剤
CA1284994C (en) * 1985-08-05 1991-06-18 Murray Arthur Kaplan Cephalosporin salts and injectable compositions

Also Published As

Publication number Publication date
GB2199746B (en) 1990-10-24
NL193266B (nl) 1999-01-04
GR871860B (en) 1988-05-10
DK166404B1 (da) 1993-05-17
CA1307464C (en) 1992-09-15
AU606361B2 (en) 1991-02-07
SE467910B (sv) 1992-10-05
NL8800025A (nl) 1988-08-01
SE8800036L (sv) 1988-07-10
CY1679A (en) 1993-10-10
FR2609396A1 (fr) 1988-07-15
NL193266C (nl) 1999-05-06
OA08796A (fr) 1989-03-31
FI875122A (fi) 1988-07-10
US4808617A (en) 1989-02-28
ATA341687A (de) 1989-01-15
BE1002114A3 (fr) 1990-07-10
HU199686B (en) 1990-03-28
IL84346A (en) 1992-05-25
SG114792G (en) 1992-12-24
HK5593A (en) 1993-02-05
DK577387A (da) 1988-07-10
PT86157A (en) 1987-12-01
HUT46223A (en) 1988-10-28
IT1215666B (it) 1990-02-22
FI89006C (fi) 1993-08-10
JP2568226B2 (ja) 1996-12-25
AU8085687A (en) 1989-05-11
JPS63208522A (ja) 1988-08-30
FR2609396B1 (fr) 1993-01-29
GB2199746A (en) 1988-07-20
SE8800036D0 (sv) 1988-01-08
GB8725875D0 (en) 1987-12-09
CS15888A2 (en) 1989-01-12
DE3740588C2 (de) 1996-07-11
DE3740588A1 (de) 1988-07-21
KR880008811A (ko) 1988-09-13
AR243501A1 (es) 1993-08-31
CH676202A5 (ja) 1990-12-28
SU1575942A3 (ru) 1990-06-30
DD264614A5 (de) 1989-02-08
PT86157B (pt) 1991-02-08
CS265249B2 (en) 1989-10-13
IE872970L (en) 1988-07-09
IL84346A0 (en) 1988-04-29
ZA88114B (ja) 1988-06-27
FI89006B (fi) 1993-04-30
KR950010154B1 (ko) 1995-09-11
IE61238B1 (en) 1994-10-19
AT388672B (de) 1989-08-10
FI875122A0 (fi) 1987-11-19
YU2388A (en) 1989-10-31
ES2008951A6 (es) 1989-08-16
DK577387D0 (da) 1987-11-03
YU46689B (sh) 1994-04-05
IT8819013A0 (it) 1988-01-07

Similar Documents

Publication Publication Date Title
EP0858325B1 (fr) Formulation pharmaceutique lyophilisee stable
LU87102A1 (fr) Combinaison iyophilisee ou precipitee de zwitterbn de cephalosporine et de sel
JPS5838421B2 (ja) 分岐鎖状ケト酸のオルニチン及びアルギニン塩並びに肝臓及び腎臓障害の治療への使用
OA10678A (fr) Nouvelles formulations liquides stables à base de paracétamol et leur mode de préparation
FR2571966A1 (fr) Compositions therapeutiques contenant des anthracyclines-glucosides.
FR2853547A1 (fr) Compositions pharmaceutiques injectables contenant de la piperacilline et du tazobactame, et procede pour leur production
FR2670487A1 (fr) Nouveau sel de 3-[2-dimethylamino)ethyl-]-n-methyl-1h-indole-5-methanesulfonamide, sa preparation et son utilisation comme medicament.
FR2464262A1 (fr) Sels de la (+)-catechine et compositions les contenant, leur preparation et leur utilisation dans le traitement des maladies degeneratives du tissu conjonctif
EP0399903A1 (fr) Nouvelles compositions à base d'imipramine
FI77156B (fi) Foerfarande foer framstaellning av en fast vismuthaltig komposition.
KR20070026187A (ko) 2개 이상의 활성 물질을 함유하는 주사용 멸균 약제학적제형
ES2536705T3 (es) Agente farmacéutico que comprende un derivado de benzamida como ingrediente activo
CA2949328C (en) Low substituted polymyxins and compositions thereof
FR2584405A1 (fr) Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation
EP1948224B1 (en) Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension
WO2005039589A2 (fr) Modulateurs des canaux cftr
FR2482458A1 (fr) Compositions antitumorales a base de methanesulfon-m-anisidine
EP2780019A1 (fr) Composition a l'etat solide comprenant un sel d'hypothiocyanite
CA1277240C (fr) Medicament modulateur de l'immunite et son procede de preparation
JP6862447B2 (ja) ダニリキシンの静脈内注射用製剤
US5164379A (en) Sucralfate/cyclodextrin complexes
FR2638968A1 (fr) Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives
FR2952M (ja)
JP4355578B2 (ja) リボフラビン系化合物を含む医薬
LU87411A1 (fr) Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique